In a filing, Immuneering Corp revealed its Director Feinberg Peter acquired Company’s shares for reported $63188.0 on Jun 18 ’25. In the deal valued at $2.53 per share,25,000 shares were bought. As a result of this transaction, Feinberg Peter now holds 136,766 shares worth roughly $0.33 million.
Then, Zeskind Benjamin J. bought 21,000 shares, generating $50,144 in total proceeds. Upon buying the shares at $2.39, the PRESIDENT AND CEO now owns 2,302,852 shares.
Before that, Schall Thomas J. bought 40,485 shares. Immuneering Corp shares valued at $89,278 were divested by the Director at a price of $2.21 per share. As a result of the transaction, Schall Thomas J. now holds 43,385 shares, worth roughly $0.11 million.
Morgan Stanley downgraded its Immuneering Corp [IMRX] rating to an Underweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in mid March has reiterated a ‘”a Buy”‘ rating for it. TD Cowen also remained covering IMRX and has decreased its forecast on March 15, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Jefferies revised its rating on March 15, 2024. It rated IMRX as “a Hold” which previously was an “a Buy”.
Price Performance Review of IMRX
On Monday, Immuneering Corp [NASDAQ:IMRX] saw its stock fall -4.69%% to $2.44. Over the last five days, the stock has gained 28.42%. Immuneering Corp shares have risen nearly 64.86% since the year began. Nevertheless, the stocks have risen 10.91% over the past one year. While a 52-week high of $3.83 was reached on 01/07/25, a 52-week low of $1.00 was recorded on 05/12/25.
Levels Of Support And Resistance For IMRX Stock
The 24-hour chart illustrates a support level at 2.30, which if violated will result in even more drops to 2.17. On the upside, there is a resistance level at 2.56. A further resistance level may holdings at 2.69.
How much short interest is there in Immuneering Corp?
A steep rise in short interest was recorded in Immuneering Corp stocks on 2025-05-30, growing by 58469.0 shares to a total of 0.92 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 0.87 million shares. There was a rise of 6.32%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 01, 2023 when Needham began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.
